Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2003-9-5
pubmed:abstractText
It is still controversial whether elevated plasma homocysteine and the C677T polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene are risk factors for stroke. The aim of the present study was to investigate the association between the 2 factors and stroke in Chinese in a large case-control study.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1524-4628
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2085-90
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:12907815-Brain Ischemia, pubmed-meshheading:12907815-Case-Control Studies, pubmed-meshheading:12907815-Cerebral Hemorrhage, pubmed-meshheading:12907815-China, pubmed-meshheading:12907815-Comorbidity, pubmed-meshheading:12907815-DNA Mutational Analysis, pubmed-meshheading:12907815-Female, pubmed-meshheading:12907815-Gene Frequency, pubmed-meshheading:12907815-Genotype, pubmed-meshheading:12907815-Homocysteine, pubmed-meshheading:12907815-Humans, pubmed-meshheading:12907815-Intracranial Thrombosis, pubmed-meshheading:12907815-Male, pubmed-meshheading:12907815-Methylenetetrahydrofolate Reductase (NADPH2), pubmed-meshheading:12907815-Middle Aged, pubmed-meshheading:12907815-Oxidoreductases Acting on CH-NH Group Donors, pubmed-meshheading:12907815-Point Mutation, pubmed-meshheading:12907815-Polymorphism, Genetic, pubmed-meshheading:12907815-Risk Assessment, pubmed-meshheading:12907815-Risk Factors, pubmed-meshheading:12907815-Stroke
pubmed:year
2003
pubmed:articleTitle
Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China.
pubmed:affiliation
Sino-German Laboratory for Molecular Medicine and Center for Molecular Cardiology, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, 167 Beilishilu, Beijing 100037, China.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study